A phase 2a study of S-637880 in patients with neuropathic low back pai
Phase 2
- Conditions
- europathic low back pain
- Registration Number
- JPRN-jRCT2031200418
- Lead Sponsor
- agata - Tsutae
- Brief Summary
Since this study was prematurely terminated at all study sites, the efficacy and safety could not be fully evaluated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
Patients who meet the following criteria:
- Patients with chronic pain located in the posterior aspect of the trunk and between the twelfth rib and the inferior end of the gluteal fold
- Patients whose average daily pain intensity are 4 or higher on Visit 1
- Patients whose weekly mean of average daily pain intensity are 4 or higher and less than 10 for 7 days including Visit 2 (Day 1) on Visit 2
Exclusion Criteria
Patients who are considered to have primary pain other than low back and leg pain or patients with neuropathic pain other than low back and leg pain
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method